Analysen von Richard Vosser
| 03.01.23 | Merck Overweight | JP Morgan Chase & Co. | |
| 03.01.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 03.01.23 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.01.23 | MorphoSys Underweight | JP Morgan Chase & Co. | |
| 03.01.23 | Bayer Neutral | JP Morgan Chase & Co. | |
| 14.11.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 11.11.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 10.11.22 | Merck Overweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 09.11.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 09.11.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 08.11.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 03.11.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 02.11.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 31.10.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 31.10.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 28.10.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 27.10.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 26.10.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.10.22 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |
| 19.10.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 18.10.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 07.10.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 05.10.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 03.10.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 21.09.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.09.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 16.09.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 12.09.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 12.09.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 08.09.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 08.09.22 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 06.09.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 31.08.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 31.08.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 30.08.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 29.08.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 25.08.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 12.08.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 09.08.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 05.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 04.08.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 04.08.22 | Merck Overweight | JP Morgan Chase & Co. | |
| 03.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 29.07.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 28.07.22 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 25.07.22 | Bayer Overweight | JP Morgan Chase & Co. | |
| 25.07.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 22.07.22 | Sartorius Stedim Biotech Overweight | JP Morgan Chase & Co. | |
| 22.07.22 | Sartorius vz. Overweight | JP Morgan Chase & Co. | |